Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Szigetvar – page 25

461 clinical trials in Szigetvar, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.

Szigetvar at a glance
461
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

461 trials in Szigetvar

Open in trial search

Study of tozorakimab effectiveness and safety in former smokers with Chronic Obstructive Pulmonary Disease (COPD) who experience disease flare-ups

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol
  • Sponsor:Astrazeneca AB

Study Comparing ABP 206 and Nivolumab for Patients with Unresectable or Metastatic Melanoma

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:Amgen Inc.

Giant cell arteritis

Not recruiting

Study of secukinumab and prednisone combination therapy for patients with giant cell arteritis (GCA): Evaluation of treatment effectiveness and safety

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Prednisone
  • Sponsor:Novartis Pharma AG

Study on Acalabrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients Without del(17p) or TP53 Mutation

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:Acerta Pharma B.V.

Lupus nephritis

Not recruiting

Study on the Effects of Ianalumab with Standard Therapy for Patients with Active Lupus Nephritis

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Emtricitabine
  • Sponsor:Novartis Pharma AG

Study on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years
  • Substances:Ofatumumab
  • Sponsor:Novartis Pharma AG

IgA nephropathy

Not recruiting

Study on the Effectiveness and Safety of Iptacopan for Patients with Primary IgA Nephropathy

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Iptacopan
  • Sponsor:Novartis Pharma AG

Acromegaly

Not recruiting

Study on the Long-Term Safety and Efficacy of Paltusotine for Patients with Acromegaly

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Paltusotine
  • Sponsor:Crinetics Pharmaceuticals Inc.

Embolism venous

Not recruiting

Study Comparing Abelacimab and Apixaban for Preventing Blood Clots in Cancer Patients

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.

Embolism venous+1

Not recruiting

Study on Abelacimab and Dalteparin for Preventing Blood Clots in Patients with Gastrointestinal or Genitourinary Cancer

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.

Study Comparing the Effectiveness and Safety of Macitentan 75 mg and 10 mg for Patients with Pulmonary Arterial Hypertension

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Macitentan
  • Sponsor:Actelion Pharmaceuticals Ltd.

Other cities in Hungary

The busiest research cities in the country

All 73 cities in Hungary

Clinical research in Szigetvar

What the registry says about research in the country

01 Respiratory Medicine

Comprehensive research focusing on severe asthma treatments, particularly in pediatric populations. Studies evaluate novel therapies including dupilumab and tezepelumab for improving respiratory function.

  • Pediatric Asthma Management
  • Severe Exacerbation Prevention
  • Respiratory Function Improvement

Multiple trials are exploring innovative approaches to control asthma symptoms in children aged 2-12 years.

02 Allergic Conditions

Investigations into allergic rhinoconjunctivitis treatments, with specific focus on birch pollen allergies. Research includes evaluation of STALORAL® Birch therapy for pediatric and adolescent patients.

  • Allergy Immunotherapy
  • Pediatric Allergy Treatment
  • Symptom Management

Studies aim to improve quality of life for young patients with seasonal allergies.

03 Cardiovascular Research

Advanced studies in heart failure prevention and cardiovascular health, including investigation of baxdrostat in combination with dapagliflozin. Additional focus on cardiovascular complications in dialysis patients.

  • Heart Failure Prevention
  • Cardiovascular Risk Management
  • ESKD-related Heart Disease

Research targets reduction of cardiovascular events and mortality in high-risk populations.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.